• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzylethers

Recent Advances in the Application of 1-Bromo-3-(dimethoxymethyl)benzene (CAS: 67073-72-7) in Chemical Biology and Pharmaceutical Research

The compound 1-Bromo-3-(dimethoxymethyl)benzene (CAS: 67073-72-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications as a key intermediate in organic synthesis. This aromatic bromo compound, characterized by a dimethoxymethyl substituent, serves as a crucial building block for the development of novel bioactive molecules, including pharmaceuticals, agrochemicals, and materials. Recent studies have highlighted its utility in cross-coupling reactions, nucleophilic substitutions, and as a precursor for complex molecular architectures.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the efficacy of 1-Bromo-3-(dimethoxymethyl)benzene in the synthesis of potent kinase inhibitors. The compound's bromo group facilitated efficient Suzuki-Miyaura cross-coupling reactions with boronic acids, enabling the rapid assembly of diverse heterocyclic scaffolds. The dimethoxymethyl moiety, meanwhile, provided a handle for further functionalization, enhancing the drug-like properties of the resulting molecules. This approach yielded several candidates with nanomolar inhibitory activity against targeted kinases, underscoring the compound's value in drug discovery.

Another notable application was reported in ACS Catalysis, where 1-Bromo-3-(dimethoxymethyl)benzene was employed in photocatalytic C-H functionalization reactions. The study revealed that the electron-rich dimethoxymethyl group stabilized radical intermediates, improving reaction yields and selectivity. This methodology was successfully applied to the late-stage diversification of pharmaceutical compounds, offering a streamlined route to analogs for structure-activity relationship studies. The findings suggest that 67073-72-7 could play a pivotal role in accelerating medicinal chemistry campaigns.

From a safety and scalability perspective, recent process chemistry research (Organic Process Research & Development, 2024) has optimized the large-scale production of 1-Bromo-3-(dimethoxymethyl)benzene. Innovations in bromination conditions and purification techniques have increased yields to >85% while reducing hazardous waste generation. These advancements address previous limitations in the compound's commercial availability, making it more accessible for industrial applications. The improved synthesis protocol maintains high purity standards (>99%), critical for pharmaceutical use.

Emerging applications in materials science have also been explored. A 2024 Nature Communications article detailed the incorporation of 67073-72-7-derived monomers into conjugated polymers for organic electronics. The dimethoxymethyl group was found to modulate the polymer's electronic properties while the bromo site enabled precise chain-length control through controlled polymerization techniques. The resulting materials exhibited enhanced charge carrier mobility, suggesting potential use in flexible electronics and bioelectronic devices.

In conclusion, 1-Bromo-3-(dimethoxymethyl)benzene (67073-72-7) continues to demonstrate remarkable versatility across multiple research domains. Its dual functionality as both an electrophilic coupling partner and a protected aldehyde precursor makes it invaluable for complex molecule construction. Recent breakthroughs in synthetic methodologies, coupled with improved manufacturing processes, position this compound as an increasingly important tool in chemical biology and pharmaceutical development. Future research directions may explore its applications in biocatalysis, targeted protein degradation, and as a linchpin in diversity-oriented synthesis platforms.

• 75148-49-1(1-bromo-3-(diethoxymethyl)benzene)
• 24856-58-4(4-Bromobenzaldehyde dimethyl acetal)
• 35849-09-3(1-Bromo-2-(dimethoxymethyl)benzene)
• 34421-94-8(4-Bromobenzaldehyde Diethyl Acetal)
• 861928-15-6(Benzene, 1,4-dibromo-2-(dimethoxymethyl)-)
• 88679-81-6(1,3-Dioxolane, 2-(4-bromo-2,6-dimethylphenyl)-)
• 17789-14-9(2-(3-Bromophenyl)-1,3-dioxolane)
• 10602-01-4(2-(4-Bromophenyl)-1,3-dioxolane)
• 104865-88-5(Benzene,1-bromo-4-(trimethoxymethyl)-)
• 157866-05-2(Benzene,1,3-dibromo-5-(dimethoxymethyl)-)